3 Ways to Mitigate the Risk of Transcatheter Heart Valve Underexpansion and Dysfunction in Valve-in-Valve TAVR
JACC: Cardiovascular Interventions · 2023
DOI: 10.1016/j.jcin.2023.02.001 ↗Kurz gefasst
Editorial in der Zeitschrift JACC: Cardiovascular Interventions, 2023. Verfasst von Frédéric Beaupré und 1 weiteren Autor:innen. Beteiligte Einrichtung: ACTION Study Group, INSERM UMRS_1166 Institut de Cardiologie, Pitié Salpêtrière (AP-HP), Paris, France. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis Implantation, Aortic Valve Stenosis, Heart Valve Prosthesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ACTION Study Group, INSERM UMRS_1166 Institut de Cardiologie, Pitié Salpêtrière (AP-HP), Paris, France.
- Institut Cardiovasculaire Paris-Sud (ICPS), Hôpital Privé Jacques Cartier, Ramsay-Santé, Massy, France. Electronic address: p.garot@angio-icps.com.
Zitieren
APA
Beaupré, F., & Garot, P. (2023). 3 Ways to Mitigate the Risk of Transcatheter Heart Valve Underexpansion and Dysfunction in Valve-in-Valve TAVR. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2023.02.001
Vancouver
Beaupré F, Garot P. 3 Ways to Mitigate the Risk of Transcatheter Heart Valve Underexpansion and Dysfunction in Valve-in-Valve TAVR. JACC: Cardiovascular Interventions. 2023. doi:10.1016/j.jcin.2023.02.001
BibTeX
@article{Beaupr2023,
author = {Beaupré, Frédéric and Garot, Philippe},
title = {3 Ways to Mitigate the Risk of Transcatheter Heart Valve Underexpansion and Dysfunction in Valve-in-Valve TAVR},
journal = {JACC: Cardiovascular Interventions},
year = {2023},
doi = {10.1016/j.jcin.2023.02.001}
}
EUVIMED